Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in children and adolescents with bipolar I disorder
NCT01124877Phase 3Withdrawn
- Sponsor
- Viatris
- Start
- Jul 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Viatris. Planned start Jul 2010; status: withdrawn.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01124877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124877.